Pham-Scottez A
Service de Psychiatrie, Hôpital Paul Brousse, Villejuif.
Presse Med. 1998 Dec 19;27(40):2145-50.
A WIDE SELECTION: New drugs have recently been added to the list of antidepressor agents which includes more than 20 compounds in 1998. The mechanisms of action are quite different.
Better knowledge of each compound and its mechanism of action on the different monoamines functioning in the brain has not been sufficient to determine a pharmacoclinical classification of depression. Likewise, alone mechanism of action is insufficient for choosing the right drug for a given individual.
Therapeutic decisions must also take into account the clinical and functional features expressed by the patient, focusing on the importance of the patient-physician relationship in treating patients with states of depression.
种类繁多:近期抗抑郁药清单中增添了多种新药,1998年该清单包含20多种化合物。其作用机制差异很大。
尽管对每种化合物及其对大脑中不同单胺功能的作用机制有了更深入了解,但仍不足以确定抑郁症的药物临床分类。同样,仅依据作用机制也不足以针对特定个体选择合适药物。
治疗决策还必须考虑患者表现出的临床和功能特征,重视医患关系在抑郁症患者治疗中的重要性。